PT Millennium Pharmacon International Tbk (IDX:SDPC)
200.00
0.00 (0.00%)
Sep 2, 2026, 11:37 AM WIB
IDX:SDPC Revenue
PT Millennium Pharmacon International Tbk had revenue of 1.11T IDR in the quarter ending June 30, 2026, with 15.66% growth. This brings the company's revenue in the last twelve months to 4.30T, up 9.67% year-over-year. In the year 2025, PT Millennium Pharmacon International Tbk had annual revenue of 4.11T with 4.93% growth.
Revenue (ttm)
4.30T
Revenue Growth
+9.67%
P/S Ratio
0.06
Revenue / Employee
3.59B
Employees
1,197
Market Cap
254.80B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.11T | 192.95B | 4.93% |
| Dec 31, 2024 | 3.92T | 553.35B | 16.45% |
| Dec 31, 2023 | 3.36T | 162.68B | 5.08% |
| Dec 31, 2022 | 3.20T | 211.98B | 7.09% |
| Dec 31, 2021 | 2.99T | 345.22B | 13.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Enseval Putera Megatrading Tbk. | 35.18T |
| PT Medela Potentia Tbk | 15.64T |
| PT Soho Global Health Tbk | 10.97T |
| PT Kimia Farma Tbk | 9.56T |
| PT Itama Ranoraya Tbk | 1.05T |
| PT Esa Medika Mandiri Tbk | 504.59B |
| PT Diastika Biotekindo Tbk | 205.27B |